Research and Markets: Competitor Analysis: Immunocytokines - 2014 Report

DUBLIN--()--Research and Markets ( has announced the addition of the "Competitor Analysis: Immunocytokines" report to their offering.

The development of recombinant cytokines, or mainly antibody-cytokine fusion proteins, has been characterized by many drawbacks from dose-limiting toxicities. Over several years, development of new cytokines has stagnated, but recent R&D work with engineering of the cytokine payloads promises new molecular entities with better tolerability and safety.

The present Competitive Intelligence report about Immunocytokines provides a competitor evaluation in the field of recombinant fusion proteins of a targeting moiety and a human cytokine as of January 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of recombinant immunocytokines with first and second generation cytokine payloads. In addition, the report lists company-specific R&D pipelines of Immunocytokines.

Competitor projects are listed in a tabular format providing information on:

- Drug Codes,

- Target / Mechanism of Action,

- Class of Compound,

- Company,

- Product Category,

- Indication,

- R&D Stage and

- additional comments with a hyperlink leading to the source of information.

Key Topics Covered:

- Immunocytokines with TNF as Payload

- Immunocytokines with First-Generation Interleukin-2 as Payload

- Immunocytokines with Second-Generation Interleukin-2 as Payload

- Immunocytokines with Interleukin-10 as Payload

- Immunocytokines with Interleukin-12 as Payload

- Immunocytokines with Interleukin-15 as Payload

- Immunocytokines with Interferon as Payload

- Corporate Immunocytokine R&D Pipelines

Companies Mentioned

- Alkermes

- Alopexx Oncology

- Altor Biosciences

- Apeiron Biologics

- AstraZeneca

- Atlab Pharma

- CytImmune

- Cytune Pharma

- ImmunGene

- Immunomedics

- Merck Serono

- MolMed

- Nektar Therapeutics

- Paladin Labs

- Pfizer

- Philogen (Philochem)

- Roche

- Targa Therapeutics

- Teva Pharmacuticcals

- Valor Biotherapeutics

For more information visit

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.


Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals